Nerlynx (Puma Biotechnology, Inc.)
Welcome to the PulseAid listing for the Nerlynx drug offered from Puma Biotechnology, Inc.. This Kinase Inhibitor [EPC],Kinase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Puma Biotechnology, Inc. |
| NON-PROPRIETARY NAME: | neratinib |
| SUBSTANCE NAME: | NERATINIB MALEATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Kinase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-07-17 |
| END MARKETING DATE: | 0000-00-00 |
Nerlynx HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nerlynx from Puma Biotechnology, Inc. |
| LABELER NAME: | Puma Biotechnology, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 40(mg/1) |
| START MARKETING DATE: | 2017-07-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70437-240_20dd2a2c-5534-4bca-91eb-90ae9692bc3d |
| PRODUCT NDC: | 70437-240 |
| APPLICATION NUMBER: | NDA208051 |
Other NERATINIB MALEATE Pharmaceutical Manufacturers / Labelers:
